发明名称 PHARMACEUTICAL COMPOSITION OF BUPROPION AND NALTREXONE
摘要 A pharmaceutical composition of bupropion or salts thereof and naltrexone or salts thereof is provided. The composition comprises individual layers of bupropion or a pharmaceutically acceptable salt thereof and naltrexone or a pharmaceutically acceptable salt thereof in direct contact with each other and without being separated by any intermediate layer. A method of manufacturing the composition is also provided.
申请公布号 US2016220562(A1) 申请公布日期 2016.08.04
申请号 US201514611267 申请日期 2015.02.01
申请人 Gravis Pharmaceuticals 发明人 Garegnani James;Kanniyappan Velayutham
分类号 A61K31/485;A61K31/137;A61K9/20;A61K9/24 主分类号 A61K31/485
代理机构 代理人
主权项 1. A pharmaceutical composition comprising: a. a first layer comprising bupropion or a pharmaceutically acceptable salt thereof; b. a second layer comprising naltrexone or a pharmaceutically acceptable salt thereof; and c. one or more pharmaceutically acceptable excipients;wherein the composition is devoid of an intermediate layer, and wherein following ingestion of the composition by a patient, the first layer of the bupropion or a pharmaceutically acceptable salt thereof dissolves as predicted by its individual dissolution profile and the second layer of the naltrexone or a pharmaceutically acceptable salt thereof dissolves as predicted by its individual dissolution profile.
地址 Somerset NJ US